Respiratory diseases are defined as the diseases that affect the nasal passage, air passage, lungs and the bronchi. Respiratory diseases range from acute condition such as common cold, pneumonia, bronchitis to chronic conditions such as chronic pulmonary obstructive diseases (COPD) and asthma. Onset of respiratory infection is provoked by number of causative agent’s namely viral pathogens, bacterial pathogens, smoking, allergens and occupational agents.
To Read the Complete Report with TOC Visit: http://www.marketresearchreports.biz/analysis-details/respiratory-disease-testing-market-global-industry-analysis-size-share-growth-trends-and-forecast-2012-2018
As cited by World Health Organization (WHO), respiratory disease has become one of the most common causes of deaths worldwide. Complications in breathing severely affect the quality of life of the patients and so rising prevalence of respiratory diseases across the globe possesses a serious threat. Asthma, a chronic disease characterized by recurrent attacks of breathlessness and COPD is a life threatening lung disease that interferes with the normal breathing. It has been estimated that currently, more than 235 million people are suffering from asthma and about 64 million people are diagnosed with COPD. Nowadays, occurrence of respiratory diseases is common in both the gender owing to increased usage of tobacco and exposure to smoke of biomass fuels used for cooking.
People suffering from the respiratory diseases require healthcare services from primary consultations to hospital admission. Thus, with the increase in demand for treatment of respiratory diseases manufactures are developing testing devices which can diagnose the diseases at an early stage. Simple diagnostic tests such as spirometer, peak flow meters, polysomnography devices and other diagnostic devices are available in the market to cater the unmet needs. For further controlling the mortality rate companies are entering into collaborations for launching diagnostic tests. Usages of these tests are procured by hospitals, physician’s offices, private/commercial labs and public health labs.
North America accounts for a larger share among all the geographies followed by Europe owing to increase in aging population, smoking and rising incidences of common COPD. However, due to increase in smoking rate, Asian countries also holds a significant share in respiratory disease testing market.
The emergence in this market is expected to show a double digit growth in the coming years owing to demographic changes, increase in the COPD cases and technological advancements which will influence the growth of this market. In addition with the growing demand for long term treatment and managing the condition acts as a driver for the growth of this market. Some of the key players in the respiratory diseases testing market include Abott, Beckman Coulter, affymetrix, biomeriux and others.
This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include
- North America
- Asia Pacific
- Rest of the World
To Buy The Copy of This Report Visit: http://www.marketresearchreports.biz/analysis/170579
MarketResearchReports.Biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are especially designed to save time and money of our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.
90 Sate Street, Suite 700
Albany, NY 12207
USA – Canada Toll Free: 866-997-4948